BioForce Nanosciences Holdings Inc. (OTCMKTS:BFNH – Get Free Report) was the target of a significant growth in short interest during the month of October. As of October 30th, there was short interest totaling 5,430 shares, a growth of 99.4% from the October 15th total of 2,723 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average trading volume of 15,872 shares, the short-interest ratio is currently 0.3 days.
BioForce Nanosciences Trading Up 4.7%
OTCMKTS:BFNH traded up $0.31 during mid-day trading on Friday, hitting $6.97. The stock had a trading volume of 4,485 shares, compared to its average volume of 6,697. The company has a 50 day simple moving average of $7.87 and a 200-day simple moving average of $2.92. BioForce Nanosciences has a 52 week low of $0.18 and a 52 week high of $10.99.
BioForce Nanosciences (OTCMKTS:BFNH – Get Free Report) last announced its quarterly earnings results on Monday, November 9th. The company reported ($0.01) EPS for the quarter.
BioForce Nanosciences Company Profile
BioForce Nanosciences is a life-sciences technology company that has focused on applying nanotechnology to biological research and diagnostic applications. The company has been based in Ames, Iowa. Its products have included the Nano eNabler, an instrument for nanoscale deposition and patterning of biological materials, and the NanoBioProcessor platform for handling and analyzing small biological samples. BioForce has also developed the ViriChip platform, intended for detecting viruses and other biological targets.
Featured Stories
- Five stocks we like better than BioForce Nanosciences
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for BioForce Nanosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioForce Nanosciences and related companies with MarketBeat.com's FREE daily email newsletter.
